Management of Tuberculous meningitis – A review

---

Review Article

Author Details : Lakshmi K., Santhanam R., Chitralekha S.

Volume : 4, Issue : 1, Year : 2017

Article Page : 1-6

Suggest article by email

Get Permission

---

Abstract

Tuberculous Meningitis (TBM) is one of the leading causes of deaths and disabilities in the developing nations like India. Rapid diagnosis of the cases is essential to minimise the mortality and morbidity. Although clinical diagnosis is made based on the presenting symptoms, signs and radiological imaging studies, confirmation of the diagnosis is still difficult and there are significant diagnostic and treatment challenges. Cerebro spinal fluid (CSF) examination shows a lymphocytic-predominant pleiocytosis, elevated protein, and normal or low glucose. Multiple and repeated Culture and CSF examination by acid fast staining and PCR usually may show good results. Empirical treatment with at least four first-line drugs, preferably isoniazid, rifampin, pyrazinamide, and streptomycin or ethambutol is usually started in clinical suspected cases with supportive initial CSF findings. Corticosteroid can be added as adjunctive treatment, but its benefits remains doubtful. Drug interactions, possibility of drug resistant tuberculosis and development of immune reconstitution inflammatory syndrome needs to be kept in mind in initiating the TBM treatment in patients who are HIV positive. This review article throws light into the current practice in the laboratory diagnosis and management of Tuberculous meningitis.

Keywords: Tuberculous Meningitis, Tuberculosis, Diagnosis, Treatment, Prognosis

How to cite : Lakshmi K., Santhanam R., Chitralekha S., Management of Tuberculous meningitis – A review. Indian J Microbiol Res 2017;4(1):1-6

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.